Comparison of TET1, TET2, and TET3 mRNA expression in patients with laryngeal cancer, oral cancer, hypopharyngeal cancer, and oropharyngeal cancer are shown in Figure S1. This evidence concerns the gene TET3 and laryngeal carcinoma.